![David F. Wiemer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David F. Wiemer
Corporate Officer/Principal chez University of Iowa
Postes actifs de David F. Wiemer
Sociétés | Poste | Début | Fin |
---|---|---|---|
University of Iowa | Corporate Officer/Principal | - | - |
Historique de carrière de David F. Wiemer
Anciens postes connus de David F. Wiemer
Sociétés | Poste | Début | Fin |
---|---|---|---|
Terpenoid Therapeutics, Inc.
![]() Terpenoid Therapeutics, Inc. Medical DistributorsDistribution Services Terpenoid Therapeutics, Inc. operates as a biotechnology company focuses on anti-cancer therapeutics. The firm engages in creating, testing, and developing novel drug candidates using cutting-edge technologies. It is focused on discovering small molecule inhibitors of geranylgeranyl diphosphate synthase, a novel target with applicability towards cancer and other indication. The company was founded by Andrew J. Wiemer, Jeffery D. Neighbors, David F. Wiemer and Raymond J. Hohl in September 2005 and is headquartered in Coralville, IA. | Directeur/Membre du Conseil | 01/09/2005 | - |
Fondateur | 01/09/2005 | - | |
Secrétaire Général | 01/09/2005 | - |
Formation de David F. Wiemer
Marquette University | Undergraduate Degree |
University of Illinois | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Director/Board Member | 1 |
Founder | 1 |
Corporate Secretary | 1 |
Sectorielle
Consumer Services | 4 |
Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Terpenoid Therapeutics, Inc.
![]() Terpenoid Therapeutics, Inc. Medical DistributorsDistribution Services Terpenoid Therapeutics, Inc. operates as a biotechnology company focuses on anti-cancer therapeutics. The firm engages in creating, testing, and developing novel drug candidates using cutting-edge technologies. It is focused on discovering small molecule inhibitors of geranylgeranyl diphosphate synthase, a novel target with applicability towards cancer and other indication. The company was founded by Andrew J. Wiemer, Jeffery D. Neighbors, David F. Wiemer and Raymond J. Hohl in September 2005 and is headquartered in Coralville, IA. | Distribution Services |
- Bourse
- Insiders
- David F. Wiemer
- Expérience